{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:23:07Z","timestamp":1778628187596,"version":"3.51.4"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1111\/1469-0691.12442","type":"journal-article","created":{"date-parts":[[2013,12,19]],"date-time":"2013-12-19T09:36:56Z","timestamp":1387445816000},"page":"92-94","source":"Crossref","is-referenced-by-count":16,"special_numbering":"S5","title":["Outlook for a dengue vaccine"],"prefix":"10.1016","volume":"20","author":[{"given":"R.","family":"Norrby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/1469-0691.12442_bib1","doi-asserted-by":"crossref","first-page":"696","DOI":"10.4161\/hv.6.9.12739","article-title":"Development of Sanofi Pasteur tetravalent dengue vaccine","volume":"6","author":"Guy","year":"2010","journal-title":"Hum Vaccin"},{"key":"10.1111\/1469-0691.12442_bib2","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1097\/INF.0b013e3181fe05af","article-title":"Live-attenuated tetravalent dengue vaccine in Dengue-naive children, adolescents and adults in Mexico city: randomized controlled phase 1 trial of safety and immunogenicity","volume":"30","author":"Poo","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/1469-0691.12442_bib3","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/S0140-6736(12)61428-7","article-title":"Protective efficacy of the recombinant, live-attenuated CYD tetravalent dengue vaccine in Thai schoolchildren: a randomized, controlled Phase 2b trial","volume":"380","author":"Sabachareon","year":"2012","journal-title":"Lancet"},{"key":"10.1111\/1469-0691.12442_bib4","doi-asserted-by":"crossref","first-page":"e1732","DOI":"10.1371\/journal.pntd.0001732","article-title":"Dengue infection in Rathchaburi, Thailand: a cohort study. I Epidemiology of symptomatic acute dengue infection in children, 2006\u20132009","volume":"6","author":"Sabchareon","year":"2012","journal-title":"PLOS Negl Trop Dis"},{"key":"10.1111\/1469-0691.12442_bib5","doi-asserted-by":"crossref","first-page":"e1520","DOI":"10.1371\/journal.pntd.0001520","article-title":"Dengue infection in children in Ratchaburi, Thailand: a cohort study. II. Clinical manifestations","volume":"6","author":"Sirivichayakul","year":"2012","journal-title":"PLOS Negl Trop Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14601816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14601816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T19:25:51Z","timestamp":1538940351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14601816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":5,"alternative-id":["S1198743X14601816"],"URL":"https:\/\/doi.org\/10.1111\/1469-0691.12442","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}